Bokang Yan

Zhuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

RPLP0 identified as a ferroptosis regulator in HCC through pan-cancer analysis.

RPLP0 identified as a ferroptosis regulator in HCC through pan-cancer analysis.

Journal: Frontiers in oncology

Published: May 26, 2026

Methodological Considerations for Further Enhancing the Clinical Impact of the deTXlon Study.

Methodological Considerations for Further Enhancing the Clinical Impact of the deTXlon Study.

Journal: Gastroenterology

Published: May 13, 2025

The multifaceted roles of ribosomal P complex in cancer.

The multifaceted roles of ribosomal P complex in cancer.

Journal: World journal of surgical oncology

Published: May 10, 2025

Letter to the Editor: Mitigating missing data bias and confounding on large-scale cohort studies of metabolic syndrome-cholangiocarcinoma associations.

Letter to the Editor: Mitigating missing data bias and confounding on large-scale cohort studies of metabolic syndrome-cholangiocarcinoma associations.

Journal: Hepatology (Baltimore, Md.)

Published: May 06, 2025

Letter to the Editor from Yan and Chang: "Long-term Nonskeletal Complications in Patients With Thyroid Cancer and Hypoparathyroidism Posttotal Thyroidectomy".

Letter to the Editor from Yan and Chang: "Long-term Nonskeletal Complications in Patients With Thyroid Cancer and Hypoparathyroidism Posttotal Thyroidectomy".

Journal: The Journal of clinical endocrinology and metabolism

Published: April 23, 2025

Targeting RPLP2 Triggers DLBCL Ferroptosis by Decreasing FXN Expression.

Targeting RPLP2 Triggers DLBCL Ferroptosis by Decreasing FXN Expression.

Journal: Biomedicines

Published: April 12, 2025

GPR34 Stabilized by Deubiquitinase USP8 Suppresses Ferroptosis of ATC.

GPR34 Stabilized by Deubiquitinase USP8 Suppresses Ferroptosis of ATC.

Journal: Mediators of inflammation

Published: April 03, 2025

Small nuclear ribonucleoprotein polypeptide B2 regulated by SNHG4/miR-204-5p axis inhibits ferroptosis to aggravate the progression of hepatocellular carcinoma.

Small nuclear ribonucleoprotein polypeptide B2 regulated by SNHG4/miR-204-5p axis inhibits ferroptosis to aggravate the progression of hepatocellular carcinoma.

Journal: Discover oncology

Published: March 22, 2025

Clinical diagnostic value of methylated SEPT9 combined with NLR, PLR and LMR in colorectal cancer.

Clinical diagnostic value of methylated SEPT9 combined with NLR, PLR and LMR in colorectal cancer.

Journal: BMC gastroenterology

Published: December 22, 2023

CPLX2 is a novel tumor suppressor and improves the prognosis in glioma.

CPLX2 is a novel tumor suppressor and improves the prognosis in glioma.

Journal: Journal of neuro-oncology

Published: September 15, 2023

Highly expressed RPLP2 inhibits ferroptosis to promote hepatocellular carcinoma progression and predicts poor prognosis.

Highly expressed RPLP2 inhibits ferroptosis to promote hepatocellular carcinoma progression and predicts poor prognosis.

Journal: Cancer cell international

Published: September 10, 2023

A pan-cancer analysis of the role of USP5 in human cancers.

A pan-cancer analysis of the role of USP5 in human cancers.

Journal: Scientific reports

Published: February 19, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026